Statistical methods for demonstrating equivalence in crossover trials based on the ratio of two location parameters

Drug Information Journal

Volumn 34, Issue 2, 2000, Pages 563-568

  Kieser, Meinhard ^a   Hauschke, Dieter ^b  

^a DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

Confidence intervals; Equivalence; Ratio of location parameters; Sample size

Indexed keywords

BIOEQUIVALENCE; CLINICAL TRIAL; CROSSOVER PROCEDURE; PRIORITY JOURNAL; REVIEW; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL MODEL;

EID: 0034039533     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150003400224     Document Type: Review

References (8)

1. European Agency for the Evaluation of Medicinal Products. Note for Guidance on Statistical Principles for Clinical Trials (ICH Topic E9). London: ICH Technical Coordination; 1998.
2. Hauschke D, Kieser M, Diletti E, Burke M. Sample size determination for proving equivalence based on the ratio of two means for normally distributed data. Stat Med. 1999;18:93-105.
3. Hauschke D, Steinijans VW, Hothorn LA. A note on Welch's approximate t-solution to bioequivalence assessment. Biometrika. 1996;83:236-237.
4. Vuorinen J, Turunen J. A simple three-step procedure for parametric and nonparametric assessment of bioequivalence. Drug Inf J. 1997;31:167-180.
5. Kieser M, Hauschke D. Approximate sample sizes for testing hypotheses about the ratio and difference of two means. J Biopharm Stat. 1999;9:641-650.
6. Hauschke D. Statistical methodology for planning and analysing safety studies. Post-doctoral thesis. University of Dortmund; 1999.
7. Bauer P, Kieser M. A unifying approach for confidence intervals and testing of equivalence and difference. Biometrika. 1996;83:934-937.
8. th International Conference of the American Lung Association and American Thoratic Society, May 18-20, 1997, San Francisco, CA.